{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:11:53Z","timestamp":1777853513768,"version":"3.51.4"},"reference-count":14,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T00:00:00Z","timestamp":1474329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Assoc Provid AIDS Care"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:p>\n                    The US treatment guidelines recommend Pneumocystis jiroveci pneumonia (PCP) prophylaxis for all HIV-infected persons with a CD4 count &lt;200 cells\/mm\n                    <jats:sup>3<\/jats:sup>\n                    (ie, eligible for PCP prophylaxis). However, some studies suggest PCP prophylaxis may be unnecessary in virally suppressed patients. Using national data of HIV-infected adults receiving medical care in the United States during 2009 to 2012, the authors assessed the weighted percentage of eligible patients who were prescribed PCP prophylaxis and the independent association between PCP prophylaxis prescription and viral suppression. Overall, 81% of eligible patients were prescribed PCP prophylaxis. Virally suppressed eligible patients were less likely to be prescribed PCP prophylaxis (prevalence ratio: 0.84; 95% confidence interval: 0.80-0.89). Although guidelines recommend PCP prophylaxis for all eligible patients, some HIV care providers might not prescribe PCP prophylaxis to virally suppressed patients. Additional data on the risk for PCP among virally suppressed patients are needed to clarify this controversy.\n                  <\/jats:p>","DOI":"10.1177\/2325957416667486","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T21:09:54Z","timestamp":1473887394000},"page":"455-458","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Prescription of\n                    <i>Pneumocystis Jiroveci<\/i>\n                    Pneumonia Prophylaxis in HIV-Infected Patients"],"prefix":"10.1177","volume":"15","author":[{"given":"Xia","family":"Lin","sequence":"first","affiliation":[{"name":"Epidemic Intelligence Service, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA"},{"name":"Division of HIV\/AIDS Prevention, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikha","family":"Garg","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS Prevention, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine L.","family":"Mattson","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS Prevention, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingwei","family":"Luo","sequence":"additional","affiliation":[{"name":"ICF International, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Skarbinski","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS Prevention, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2016,9,20]]},"reference":[{"key":"bibr1-2325957416667486","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833a3967"},{"key":"bibr2-2325957416667486","doi-asserted-by":"publisher","DOI":"10.1086\/597468"},{"key":"bibr3-2325957416667486","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.880"},{"key":"bibr4-2325957416667486","unstructured":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf. Published May 2013. Updated August 2016. Accessed August 2016."},{"key":"bibr5-2325957416667486","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028570"},{"key":"bibr6-2325957416667486","doi-asserted-by":"publisher","DOI":"10.1086\/655761"},{"key":"bibr7-2325957416667486","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2012.0303"},{"key":"bibr8-2325957416667486","unstructured":"Centers for Disease Control and Prevention. Behavioral and Clinical Characteristics of Persons Receiving Medical Care for HIV Infection\u2014Medical Monitoring Project, United States, 2011. HIV Surveillance Special Report 10. http:\/\/www.cdc.gov\/hiv\/library\/reports\/surveillance\/#special. Published January 2015. Accessed August 2016."},{"key":"bibr9-2325957416667486","unstructured":"Centers for Disease Control and Prevention. Distinguishing public health research and public health nonresearch. 2010. http:\/\/www.cdc.gov\/od\/science\/integrity\/docs\/cdc-policy-distinguishing-public-health-research-nonresearch.pdf. Accessed August 2016."},{"key":"bibr10-2325957416667486","doi-asserted-by":"publisher","DOI":"10.1086\/511862"},{"key":"bibr11-2325957416667486","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200003100-00011"},{"key":"bibr12-2325957416667486","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32826fb6fc"},{"key":"bibr13-2325957416667486","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-126"},{"key":"bibr14-2325957416667486","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.6.1888"}],"container-title":["Journal of the International Association of Providers of AIDS Care (JIAPAC)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2325957416667486","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2325957416667486","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2325957416667486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:53:45Z","timestamp":1777503225000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2325957416667486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,20]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1177\/2325957416667486"],"URL":"https:\/\/doi.org\/10.1177\/2325957416667486","relation":{},"ISSN":["2325-9582","2325-9582"],"issn-type":[{"value":"2325-9582","type":"print"},{"value":"2325-9582","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,20]]}}}